Cholera Vaccines Market Size, Share, Growth Analysis, By End user(Hospitals, specialty clinics, research and academic laboratories and pharmaceutical and biotechnology companies and others), By Type(Dukoral, Shanchol, Vaxchora, Euvichol), By Region - Industry Forecast 2024-2031

Global Cholera Vaccines Market was valued at USD 73.69 million in 2022, and is expected to rise from USD 79.07 million in 2023 to reach a value of USD 138.93 million by 2031, rising at a CAGR of 7.30 % during the forecast period 2024-2031.

Tainted food and water transmit the bacterial infections that cause cholera and affect the intestines. In addition to muscle cramps and dry mucous membranes like those on the inside of the mouth, throat, nose, and eyelids, it causes severe diarrhea, dehydration, abdominal pain, fever, a quick heartbeat, loss of skin elasticity, low blood pressure, and rapid heart rate. Currently, it threatens public health globally, but vaccination can stop it. The cholera vaccine exposes the body to a small number of live cholera bacteria, aiding in the development of immunity. It can be administered intravenously, intramuscularly, or orally. A biological preparation known as a vaccine helps the immune system develop and gives immunity to specific infectious illnesses. Many international institutions, like the World Health Organization, employ vaccines to treat infectious diseases (WHO). One contagious sickness known as cholera is brought on by consuming food or water tainted with the vibrio cholera bacterium. The infection is characterized by profuse watery diarrhea and has a brief incubation period of a few hours to five days. Sometimes cholera can be lethal. The disease is intimately associated with unhygienic behavior, inadequate sanitization, and a lack of safe drinking water. It occurs in both endemic and epidemic patterns.

US Cholera Vaccines Market is poised to grow at a sustainable CAGR for the next forecast year.